CBMX Share Price

Open 2.45 Change Price %
High 2.75 1 Day 0.25 10.00
Low 2.45 1 Week -0.05 -1.79
Close 2.75 1 Month 0.05 1.85
Volume 153109 1 Year 2.03 281.94
52 Week High 7.96
52 Week Low 0.00
CBMX Important Levels
Resistance 2 3.03
Resistance 1 2.91
Pivot 2.65
Support 1 2.59
Support 2 2.47
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

CombiMatrix Corporation (NASDAQ: CBMX)

CBMX Technical Analysis 1.5
As on 6th Dec 2016 CBMX Share Price closed @ 2.75 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3.20 & Buy for SHORT-TERM with Stoploss of 2.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
CBMX Target for December
1st Target up-side 3.97
2nd Target up-side 4.79
3rd Target up-side 5.61
1st Target down-side 1.63
2nd Target down-side 0.81
3rd Target down-side -0.01
CBMX Other Details
Segment EQ
Market Capital 4709813.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.combimatrix.com
CBMX Address
CBMX
300 Goddard
Suite 100
Irvine, CA 92618
United States
Phone: 949-753-0624
Interactive Technical Analysis Chart CombiMatrix Corporation ( CBMX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CombiMatrix Corporation
CBMX Business Profile
CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc. located in Irvine, California. The Company operates as a diagnostics reference laboratory, providing DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics. The Company's BAC arrays enable the Company to perform aCGH studies to evaluate genomic alterations. The Company's oligo arrays allow the Company to perform aCGH on a much more refined scale than is possible with BAC technology. During the year ended December 31, 2011, it also owns a 33% interest in Leuchemix, Inc. (Leuchemix), a private drug development company focused on developing a series of compounds to address a number of oncology-related diseases.